Characterization and Clonal Diffusion of Ceftaroline Non-Susceptible MRSA in Two Hospitals in Central Italy

Background: Ceftaroline represents a novel fifth-generation cephalosporin to treat infections caused by methicillin-resistant Staphylococcus aureus (MRSA). Methods: Ceftaroline susceptibility of 239 MRSA isolates was assessed by disk diffusion and a MIC test strip following both EUCAST and CLSI guid...

Full description

Bibliographic Details
Main Authors: Gianluca Morroni, Simona Fioriti, Federica Salari, Andrea Brenciani, Lucia Brescini, Marina Mingoia, Eleonora Giovanetti, Antonella Pocognoli, Andrea Giacometti, Elisa Molinelli, Annamaria Offidani, Oriana Simonetti, Oscar Cirioni
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/10/8/1026
_version_ 1797524869189992448
author Gianluca Morroni
Simona Fioriti
Federica Salari
Andrea Brenciani
Lucia Brescini
Marina Mingoia
Eleonora Giovanetti
Antonella Pocognoli
Andrea Giacometti
Elisa Molinelli
Annamaria Offidani
Oriana Simonetti
Oscar Cirioni
author_facet Gianluca Morroni
Simona Fioriti
Federica Salari
Andrea Brenciani
Lucia Brescini
Marina Mingoia
Eleonora Giovanetti
Antonella Pocognoli
Andrea Giacometti
Elisa Molinelli
Annamaria Offidani
Oriana Simonetti
Oscar Cirioni
author_sort Gianluca Morroni
collection DOAJ
description Background: Ceftaroline represents a novel fifth-generation cephalosporin to treat infections caused by methicillin-resistant Staphylococcus aureus (MRSA). Methods: Ceftaroline susceptibility of 239 MRSA isolates was assessed by disk diffusion and a MIC test strip following both EUCAST and CLSI guidelines. Non-susceptible isolates were epidemiologically characterized by pulsed-field gel electrophoresis, spa typing, and multilocus sequence typing, and further investigated by PCR and whole genome sequencing to detect penicillin-binding protein (PBP) mutations as well as antibiotic resistance and virulence genes. Results: Fourteen isolates out of two hundred and thirty-nine (5.8%) were non-susceptible to ceftaroline (MIC > 1 mg/L), with differences between the EUCAST and CLSI interpretations. The characterized isolates belonged to seven different pulsotypes and three different clones (ST228/CC5-t041-SCC<i>mec</i>I, ST22/CC22-t18014-SCC<i>mec</i>IV, and ST22/CC22-t022-SCC<i>mec</i>IV), confirming a clonal diffusion of ceftaroline non-susceptible strains. Mutations in PBPs involved PBP2a for ST228-t041-SCC<i>mec</i>I strains and all the other PBPs for ST22-t18014-SCC<i>mec</i>IV and ST22-t022-SCC<i>mec</i>IV clones. All isolates harbored antibiotic resistance and virulence genes with a clonal distribution. Conclusion: Our study demonstrated that ceftaroline non-susceptibile isolates belonged not only to ST228 strains (the most widespread clone in Italy) but also to ST22, confirming the increasing role of these clones in hospital infections.
first_indexed 2024-03-10T09:03:41Z
format Article
id doaj.art-cc4ad333bc2f4da680d982141988a7f2
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-03-10T09:03:41Z
publishDate 2021-08-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-cc4ad333bc2f4da680d982141988a7f22023-11-22T06:34:53ZengMDPI AGAntibiotics2079-63822021-08-01108102610.3390/antibiotics10081026Characterization and Clonal Diffusion of Ceftaroline Non-Susceptible MRSA in Two Hospitals in Central ItalyGianluca Morroni0Simona Fioriti1Federica Salari2Andrea Brenciani3Lucia Brescini4Marina Mingoia5Eleonora Giovanetti6Antonella Pocognoli7Andrea Giacometti8Elisa Molinelli9Annamaria Offidani10Oriana Simonetti11Oscar Cirioni12Department of Biomedical Sciences and Public Health, Polytechnic University of Marche, 60126 Ancona, ItalyDepartment of Biomedical Sciences and Public Health, Polytechnic University of Marche, 60126 Ancona, ItalyDepartment of Biomedical Sciences and Public Health, Polytechnic University of Marche, 60126 Ancona, ItalyDepartment of Biomedical Sciences and Public Health, Polytechnic University of Marche, 60126 Ancona, ItalyDepartment of Biomedical Sciences and Public Health, Polytechnic University of Marche, 60126 Ancona, ItalyDepartment of Biomedical Sciences and Public Health, Polytechnic University of Marche, 60126 Ancona, ItalyDepartment of Life and Environmental Sciences, Polytechnic University of Marche, 60126 Ancona, ItalyClinical Microbiology Laboratory, “Ospedali Riuniti”, 60126 Ancona, ItalyDepartment of Biomedical Sciences and Public Health, Polytechnic University of Marche, 60126 Ancona, ItalyDermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60126 Ancona, ItalyDermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60126 Ancona, ItalyDermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60126 Ancona, ItalyDepartment of Biomedical Sciences and Public Health, Polytechnic University of Marche, 60126 Ancona, ItalyBackground: Ceftaroline represents a novel fifth-generation cephalosporin to treat infections caused by methicillin-resistant Staphylococcus aureus (MRSA). Methods: Ceftaroline susceptibility of 239 MRSA isolates was assessed by disk diffusion and a MIC test strip following both EUCAST and CLSI guidelines. Non-susceptible isolates were epidemiologically characterized by pulsed-field gel electrophoresis, spa typing, and multilocus sequence typing, and further investigated by PCR and whole genome sequencing to detect penicillin-binding protein (PBP) mutations as well as antibiotic resistance and virulence genes. Results: Fourteen isolates out of two hundred and thirty-nine (5.8%) were non-susceptible to ceftaroline (MIC > 1 mg/L), with differences between the EUCAST and CLSI interpretations. The characterized isolates belonged to seven different pulsotypes and three different clones (ST228/CC5-t041-SCC<i>mec</i>I, ST22/CC22-t18014-SCC<i>mec</i>IV, and ST22/CC22-t022-SCC<i>mec</i>IV), confirming a clonal diffusion of ceftaroline non-susceptible strains. Mutations in PBPs involved PBP2a for ST228-t041-SCC<i>mec</i>I strains and all the other PBPs for ST22-t18014-SCC<i>mec</i>IV and ST22-t022-SCC<i>mec</i>IV clones. All isolates harbored antibiotic resistance and virulence genes with a clonal distribution. Conclusion: Our study demonstrated that ceftaroline non-susceptibile isolates belonged not only to ST228 strains (the most widespread clone in Italy) but also to ST22, confirming the increasing role of these clones in hospital infections.https://www.mdpi.com/2079-6382/10/8/1026ceftarolineMRSApenicillin-binding proteinsSCC<i>mec</i>
spellingShingle Gianluca Morroni
Simona Fioriti
Federica Salari
Andrea Brenciani
Lucia Brescini
Marina Mingoia
Eleonora Giovanetti
Antonella Pocognoli
Andrea Giacometti
Elisa Molinelli
Annamaria Offidani
Oriana Simonetti
Oscar Cirioni
Characterization and Clonal Diffusion of Ceftaroline Non-Susceptible MRSA in Two Hospitals in Central Italy
Antibiotics
ceftaroline
MRSA
penicillin-binding proteins
SCC<i>mec</i>
title Characterization and Clonal Diffusion of Ceftaroline Non-Susceptible MRSA in Two Hospitals in Central Italy
title_full Characterization and Clonal Diffusion of Ceftaroline Non-Susceptible MRSA in Two Hospitals in Central Italy
title_fullStr Characterization and Clonal Diffusion of Ceftaroline Non-Susceptible MRSA in Two Hospitals in Central Italy
title_full_unstemmed Characterization and Clonal Diffusion of Ceftaroline Non-Susceptible MRSA in Two Hospitals in Central Italy
title_short Characterization and Clonal Diffusion of Ceftaroline Non-Susceptible MRSA in Two Hospitals in Central Italy
title_sort characterization and clonal diffusion of ceftaroline non susceptible mrsa in two hospitals in central italy
topic ceftaroline
MRSA
penicillin-binding proteins
SCC<i>mec</i>
url https://www.mdpi.com/2079-6382/10/8/1026
work_keys_str_mv AT gianlucamorroni characterizationandclonaldiffusionofceftarolinenonsusceptiblemrsaintwohospitalsincentralitaly
AT simonafioriti characterizationandclonaldiffusionofceftarolinenonsusceptiblemrsaintwohospitalsincentralitaly
AT federicasalari characterizationandclonaldiffusionofceftarolinenonsusceptiblemrsaintwohospitalsincentralitaly
AT andreabrenciani characterizationandclonaldiffusionofceftarolinenonsusceptiblemrsaintwohospitalsincentralitaly
AT luciabrescini characterizationandclonaldiffusionofceftarolinenonsusceptiblemrsaintwohospitalsincentralitaly
AT marinamingoia characterizationandclonaldiffusionofceftarolinenonsusceptiblemrsaintwohospitalsincentralitaly
AT eleonoragiovanetti characterizationandclonaldiffusionofceftarolinenonsusceptiblemrsaintwohospitalsincentralitaly
AT antonellapocognoli characterizationandclonaldiffusionofceftarolinenonsusceptiblemrsaintwohospitalsincentralitaly
AT andreagiacometti characterizationandclonaldiffusionofceftarolinenonsusceptiblemrsaintwohospitalsincentralitaly
AT elisamolinelli characterizationandclonaldiffusionofceftarolinenonsusceptiblemrsaintwohospitalsincentralitaly
AT annamariaoffidani characterizationandclonaldiffusionofceftarolinenonsusceptiblemrsaintwohospitalsincentralitaly
AT orianasimonetti characterizationandclonaldiffusionofceftarolinenonsusceptiblemrsaintwohospitalsincentralitaly
AT oscarcirioni characterizationandclonaldiffusionofceftarolinenonsusceptiblemrsaintwohospitalsincentralitaly